Compare · head to head
Aemetis vs Lexicon Pharmaceuticals
Lexicon Pharmaceuticals ranks higher overall — 360 rank 28 vs 26.
Lexicon Pharmaceuticals leads on Quality (43 vs 36). Aemetis leads on Growth (62 vs 45). The two are close on Safety and Sentiment.
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | USA | USA |
| Sector | Energy & Oil | Health Care |
| Industry | Oil, Gas & Consumable Fuels | Pharmaceuticals |
| Size | Small | Small |
| ISIN | US00770K2024 | US5288723027 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 26 | 28 |
| Value | 38 | NR |
| Quality | 36 | 43 |
| Growth | 62 | 45 |
| Safety | 31 | 32 |
| Sentiment | 56 | 57 |
| Quality details | ||
| Profitability | 20 | 35 |
| Cash Truth | 53 | NR |
Aemetis vs SuncorAemetis vs Scage FutureAemetis vs Qnity ElectronicsAemetis vs New Horizon AircraftAdd a third stock →
Full analyses: Aemetis · Lexicon Pharmaceuticals
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100